Brief: MYnd Analytics And Emmaus Life Sciences Stockholders Approve Merger And Spin-Off Transactions
July 10 (Reuters) - MYnd Analytics Inc MYND.O :
* MYND ANALYTICS AND EMMAUS LIFE SCIENCES STOCKHOLDERS
APPROVE
MERGER AND SPIN-OFF TRANSACTIONS
* MYND ANALYTICS INC - COMPANIES HAVE SET A SPIN-OFF RECORD
DATE
OF JULY 15, 2019 IN ORDER TO COMPLY WITH CERTAIN NASDAQ AND DTC
REQUIREMENTS
Source text for Eikon: ID:nGNX5HBxfX
Further company coverage: MYND.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Emmaus Life Sciences
See all newsEmmaus Life Sciences Q2 revenue soars on licensing deal
Emmaus Life Sciences Q1 revenue falls driven by lower sales in U.S.
Brief: Emmaus Life Sciences Enters License And Distribution Agreement With Neoimmunetech
Emmaus Life Sciences Q3 revenue falls 38%, swings to loss
Brief: Emmaus Life Sciences CFO Yasushi Nagasaki Resigns